tiprankstipranks
Trending News
More News >
TruBridge (TBRG)
NASDAQ:TBRG
Advertisement

TruBridge (TBRG) AI Stock Analysis

Compare
217 Followers

Top Page

TBRG

TruBridge

(NASDAQ:TBRG)

Rating:57Neutral
Price Target:
$20.00
▲(1.47% Upside)
TruBridge's overall stock score is primarily impacted by its financial performance, which shows stability but faces profitability challenges. Technical analysis indicates bearish momentum, and valuation metrics highlight ongoing financial struggles. The earnings call provides some optimism with strategic initiatives, but revenue and client retention issues remain concerns.

TruBridge (TBRG) vs. SPDR S&P 500 ETF (SPY)

TruBridge Business Overview & Revenue Model

Company DescriptionTruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.
How the Company Makes MoneyTruBridge generates revenue primarily through its services in revenue cycle management and healthcare consulting. Key revenue streams include fees charged for software subscriptions, consulting services, and performance-based contracts with healthcare providers. The company also benefits from partnerships with technology providers and healthcare organizations, which can enhance its service offerings and expand its client base. Additionally, TBRG may earn revenue through training and support services for its clients, further solidifying its presence in the healthcare market.

TruBridge Earnings Call Summary

Earnings Call Date:Aug 08, 2025
(Q2-2025)
|
% Change Since: -6.98%|
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with notable growth in bookings and profitability improvements but faced challenges with revenue being lower than expected and client retention issues. The collaboration with Microsoft is a positive strategic development, but delayed revenue recognition from larger deals is a concern.
Q2-2025 Updates
Positive Updates
Bookings Growth
Bookings came in at $25.6 million on a TCV basis, a 10% increase year-over-year, and $19.6 million on an ACV basis, up 13% sequentially.
Profitability and Cash Flow
Adjusted EBITDA was $13.7 million, slightly ahead of the midpoint, with a revised EBITDA margin outlook of 18.5% at the midpoint, up from 17%. Cash flow from operations was $14.5 million for the first half of 2025, an increase of $2.8 million compared to the prior year.
AI and Microsoft Collaboration
TruBridge is collaborating with Microsoft to integrate Microsoft Dragon Copilot into their EHR solution, enhancing care delivery and operational efficiency for rural and community health care clients.
Negative Updates
Revenue Lower Than Expected
Revenue of $85.7 million came in towards the lower end of expectations, and the top end of the revenue range for the year has been lowered.
CBO Client Retention Challenges
Client retention in the CBO side of the Financial Health business was slightly lower than forecasted, affecting revenue outlook.
Delayed Revenue Recognition
Success in bookings and larger deals leads to delayed revenue recognition, with some deals not contributing to revenue until 2026.
Company Guidance
During the TruBridge Q2 2025 earnings call, the company provided updated guidance and discussed several key metrics for the quarter. Bookings were reported at $25.6 million on a TCV basis, with revenue totaling $85.7 million, which was towards the lower end of expectations. However, adjusted EBITDA was $13.7 million, slightly ahead of the midpoint of previous guidance. The company decided to revise its full-year guidance, lowering the top end of the revenue range to between $345 million and $350 million, but raising the adjusted EBITDA range to between $62 million and $67 million. TruBridge highlighted its focus on operational improvements, driving efficiencies, and unlocking the value of its existing customer base as crucial to achieving its long-term objectives. Additionally, despite a slight decline in client retention on the CBO side, the company remains optimistic about future improvements. It also noted that larger deals, which take longer to implement, have affected their short-term revenue outlook, but they expect these deals to contribute positively in 2026.

TruBridge Financial Statement Overview

Summary
TruBridge shows solid revenue growth and a strong balance sheet with low leverage, indicating financial stability. However, persistent net losses highlight profitability challenges. Cash flows are robust, supporting operational needs, but improving profitability is crucial for financial health.
Income Statement
65
Positive
TruBridge's TTM (Trailing-Twelve-Months) revenue shows modest growth, but net income remains negative, impacting net profit margins adversely. Gross profit margin is healthy at approximately 49.3%, indicating efficient cost management. However, negative net profit margins and fluctuating EBIT margins suggest challenges in profitability and operational efficiency.
Balance Sheet
75
Positive
The company's balance sheet reflects a strong equity position with an equity ratio of 43.3%. The debt-to-equity ratio is low at approximately 0.03, indicating low leverage and reduced financial risk. Despite this, a decline in total assets over time suggests potential concerns in asset management or reinvestment strategies.
Cash Flow
70
Positive
TruBridge's TTM (Trailing-Twelve-Months) operating cash flow is robust, leading to a favorable operating cash flow to net income ratio. Free cash flow has shown growth, but the free cash flow to net income ratio highlights issues due to negative net income figures. Overall, cash flow management appears strong despite profitability challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue346.61M342.65M339.44M326.65M280.63M264.49M
Gross Profit170.82M174.12M163.57M160.11M144.85M136.25M
EBITDA33.38M34.94M-15.39M47.73M43.11M35.56M
Net Income-17.25M-20.44M-45.79M15.87M18.43M14.25M
Balance Sheet
Total Assets388.84M394.43M434.42M430.96M383.35M326.27M
Cash, Cash Equivalents and Short-Term Investments10.12M12.32M3.85M6.95M11.43M12.67M
Total Debt5.04M174.81M203.29M147.24M106.46M83.43M
Total Liabilities220.33M225.74M247.80M199.25M160.78M126.27M
Stockholders Equity168.51M168.69M186.62M231.71M222.57M200.00M
Cash Flow
Free Cash Flow25.49M13.04M-22.35M13.01M37.46M42.48M
Operating Cash Flow39.93M32.13M1.06M32.38M47.74M49.14M
Investing Cash Flow-14.51M4.12M-60.11M-62.73M-69.92M-6.66M
Financing Cash Flow-19.41M-27.74M55.95M25.88M20.93M-37.16M

TruBridge Technical Analysis

Technical Analysis Sentiment
Negative
Last Price19.71
Price Trends
50DMA
21.99
Negative
100DMA
23.49
Negative
200DMA
22.82
Negative
Market Momentum
MACD
-0.85
Positive
RSI
37.38
Neutral
STOCH
47.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Negative. The current price of 19.71 is below the 20-day moving average (MA) of 20.65, below the 50-day MA of 21.99, and below the 200-day MA of 22.82, indicating a bearish trend. The MACD of -0.85 indicates Positive momentum. The RSI at 37.38 is Neutral, neither overbought nor oversold. The STOCH value of 47.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TBRG.

TruBridge Risk Analysis

TruBridge disclosed 44 risk factors in its most recent earnings report. TruBridge reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

TruBridge Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$369.81M21.7411.03%6.96%1.79%8.48%
68
Neutral
$293.33M-8.21%25.90%46.13%
64
Neutral
$372.94M21.1758.01%3.05%-4.08%-36.73%
60
Neutral
$290.84M47.47-41.49%0.43%20.01%-750.59%
57
Neutral
$293.18M-6.81%3.42%77.05%
46
Neutral
C$209.14M-0.30-24.12%3.18%19.38%-2.35%
44
Neutral
$211.12M-28.42%5.55%-0.99%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TBRG
TruBridge
19.39
7.18
58.80%
SLP
Simulations Plus
14.04
-22.79
-61.88%
SPOK
Spok Holdings
17.95
4.01
28.77%
OPRX
OptimizeRx
15.49
6.89
80.12%
NRC
National Research
15.72
-5.55
-26.09%
HCAT
Health Catalyst
3.06
-4.21
-57.91%

TruBridge Corporate Events

Executive/Board ChangesShareholder Meetings
TruBridge Announces Governance Changes at Annual Meeting
Neutral
May 8, 2025

At the 2025 Annual Meeting held on May 8, 2025, TruBridge, Inc. announced significant corporate governance changes and approvals. The company’s stockholders approved the declassification of the Board of Directors, which will take effect starting with the 2026 Annual Meeting. Additionally, the Second Amended and Restated 2019 Incentive Plan was approved to increase the number of shares available for issuance. Other key decisions included the re-election of Class II directors, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent registered public accountants for 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025